Published in J Gen Virol on January 01, 1980
A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells. J Virol (1988) 1.90
Cloning and expression of the chromosomal immune interferon gene of the rat. EMBO J (1985) 1.47
Reduced synthesis of pp60src and expression of the transformation-related phenotype in interferon-treated Rous sarcoma virus-transformed rat cells. Mol Cell Biol (1983) 0.96
Structure and expression in Escherichia coli of a cloned rat interferon-alpha gene. Nucleic Acids Res (1984) 0.91
Gamma interferon-mediated inhibition of Eimeria vermiformis growth in cultured fibroblasts and epithelial cells. Infect Immun (1991) 0.91
Genetic variation in the ability of several strains of rats to produce interferon in response to polyriboinosinic-polyribocytodilic acid. Infect Immun (1984) 0.86
Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature (1988) 5.99
The hepatitis delta (delta) virus possesses a circular RNA. Nature (1986) 4.00
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science (1986) 3.33
Cloned HBV DNA causes hepatitis in chimpanzees. Nature (1982) 2.80
The purification and characterization of rat gamma interferon by use of two monoclonal antibodies. J Gen Virol (1986) 2.29
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation (1999) 2.27
Infectious hepatitis B virus from cloned DNA of known nucleotide sequence. Proc Natl Acad Sci U S A (1985) 2.20
Variability of relative blood volume during haemodialysis. Nephrol Dial Transplant (2000) 2.10
Sequential measurements of soluble interleukin 2 receptor levels in plasma of heart transplant recipients. Transplantation (1990) 2.06
Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet (1988) 1.95
[Twenty-five years of cyclosporin use in transplantation medicine]. Ned Tijdschr Geneeskd (2003) 1.94
A criminological perspective: why prohibition of organ trade is not effective and how the Declaration of Istanbul can move forward. Am J Transplant (2011) 1.92
Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year. Am J Transplant (2012) 1.79
Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol (1995) 1.63
Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J Immunol Methods (1985) 1.62
Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation (2000) 1.55
Hepatitis B virus antigens made in microbial cells immunise against viral infection. EMBO J (1984) 1.54
Contrasting response to cyclosporin in refractory nephrotic syndrome. Clin Nephrol (1989) 1.48
Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology (1989) 1.47
Cloning and expression of the chromosomal immune interferon gene of the rat. EMBO J (1985) 1.47
Ultrafiltration improves aortic compliance in haemodialysis patients. J Hum Hypertens (2005) 1.46
Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction. Transplantation (2000) 1.43
Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev (2007) 1.43
The TNF-alpha system in heart failure and after heart transplantation: plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity. Eur Heart J (1999) 1.42
The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther (1998) 1.42
Hepatitis B and hemodialysis: the impact of universal precautions in preventing the transmission of bloodborne viruses. Infect Control Hosp Epidemiol (1998) 1.41
Successful treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrol Dial Transplant (1995) 1.41
Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol (2010) 1.41
Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection. Transplantation (2000) 1.40
Increase in blood volume during dialysis without ultrafiltration. Blood Purif (2001) 1.40
[Pulmonary infection with Coccidioides immitis]. Ned Tijdschr Geneeskd (1996) 1.39
Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proc Natl Acad Sci U S A (1990) 1.39
[Favourable results of the first 2 years of the Dutch paired, living donor, kidney exchange programme]. Ned Tijdschr Geneeskd (2007) 1.39
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation (2001) 1.39
[Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results]. Ned Tijdschr Geneeskd (2003) 1.38
[Neurological complications of infectious mononucleosis in 3 patients]. Ned Tijdschr Geneeskd (1994) 1.37
Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection. Antiviral Res (1993) 1.37
Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet (1984) 1.37
The cost-effectiveness of drug regulation: the example of thorough QT/QTc studies. Clin Pharmacol Ther (2011) 1.32
Cytokines and the immune response. Biotherapy (1996) 1.15
Auxiliary partial liver transplantation for end-stage chronic liver disease. N Engl J Med (1988) 1.14
Isolation and characterization of monoclonal antibodies directed to rat interferon-gamma. Lymphokine Res (1989) 1.13
Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J Gen Virol (1994) 1.12
Taking immunogenicity assessment of therapeutic proteins to the next level. Biologicals (2011) 1.12
Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation (2001) 1.10
Induction of natural killer cell activity and allocytotoxicity in human peripheral blood lymphocytes after mixed lymphocyte culture. Scand J Immunol (1981) 1.10
Glomerular mesangial cells in local inflammation. Induction of the expression of MHC class II antigens by IFN-gamma. J Immunol (1989) 1.09
[Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis]. Ned Tijdschr Geneeskd (1993) 1.06
Protective immunisation against hepatitis B with an internal antigen of the virus. J Med Virol (1987) 1.05
Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics. Am J Transplant (2008) 1.05
Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis. Lancet (1980) 1.02
Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe. Clin Pharmacol Ther (2010) 1.01
Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator. Lancet (1981) 1.01
The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis. Transplantation (2003) 1.01
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med (1989) 1.01
Cloning, expression, and purification of rat IFN-gamma. Methods Enzymol (1986) 1.00
Antiviral effect of interferon in vivo may be mediated by the host. Nature (1979) 1.00
Mechanism of escape of exoerythrocytic forms (EEF) of malaria parasites from the inhibitory effects of interferon-gamma. J Immunol (1987) 0.99
Changes in immunological parameters after conversion from cyclosporine A to azathioprine in renal transplant recipients. Int J Immunopharmacol (1989) 0.99
Identification and transmission of hepatitis B virus-related variants. Proc Natl Acad Sci U S A (1986) 0.99
Ischemia times and donor serum creatinine in relation to renal graft failure. Transplantation (2003) 0.99
Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sci (Lond) (1992) 0.98
Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation (1986) 0.98
Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells. J Gen Virol (1991) 0.97
Follicular T helper cells and humoral reactivity in kidney transplant patients. Clin Exp Immunol (2015) 0.96
Reduced synthesis of pp60src and expression of the transformation-related phenotype in interferon-treated Rous sarcoma virus-transformed rat cells. Mol Cell Biol (1983) 0.96
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). Am J Transplant (2013) 0.96
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study. Nephrol Dial Transplant (1999) 0.96
Iatrogenic meningitis by Streptococcus salivarius following lumbar puncture. J Hosp Infect (1995) 0.96
Technical considerations and pitfalls in laparoscopic live donornephrectomy. Surg Endosc (2002) 0.95
Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart. Am J Transplant (2008) 0.95
Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients. Transplantation (1999) 0.95
Long-term graft survival after urological complications of 695 kidney transplantations. J Urol (2001) 0.94
Simple method for measuring growth inhibition by interferon of cells in monolayer. J Virol Methods (1980) 0.94
Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient. Cancer (1985) 0.94
Hypotension during hemodialysis results from an impairment of arteriolar tone and left ventricular function. Clin Nephrol (2005) 0.93
Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. Cancer Res (1978) 0.93
The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients. Transpl Immunol (2012) 0.93
Influenza vaccination in dialysis and transplant patients. Antiviral Res (1985) 0.92
Coronary artery disease after heart transplantation: timing of coronary arteriography. J Heart Lung Transplant (1993) 0.92
Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells. Transplantation (1987) 0.92
Plasmodium falciparum: studies on mature exoerythrocytic forms in the liver of the chimpanzee, Pan troglodytes. Exp Parasitol (1990) 0.91
Structure and expression in Escherichia coli of a cloned rat interferon-alpha gene. Nucleic Acids Res (1984) 0.91
Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region. J Infect Dis (1994) 0.91
Long-term follow-up of a randomized trial comparing laparoscopic and mini-incision open live donor nephrectomy. Am J Transplant (2010) 0.91
Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant (2001) 0.91
The Jak inhibitor CP-690,550 preserves the function of CD4CD25FoxP3 regulatory T cells and inhibits effector T cells. Am J Transplant (2010) 0.91
Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody. Clin Exp Immunol (1989) 0.90
The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins. Clin Exp Immunol (2010) 0.90
Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components. Vaccine (1987) 0.90
Live donor nephrectomy and return to work: does the operative technique matter? Surg Endosc (2003) 0.89
Infections after renal allograft failure in patients with or without low-dose maintenance immunosuppression. Transplantation (1997) 0.89
A controlled study on the effect of mannitol on immediate renal function after cadaver donor kidney transplantation. Transplantation (1983) 0.89
Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience. Infection (1993) 0.89
Successful expansion of the living donor pool by alternative living donation programs. Am J Transplant (2009) 0.89
CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant (2006) 0.89
The Dutch algorithm for allocation in living donor kidney exchange. Transplant Proc (2005) 0.88